- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- SBI LIFE INSURANCE
SBI LIFE INSURANCE Share Price 
(SLIC)
Here is the latest stock price and chart of Sbi Life Insurance .
| Live BSE Quotes | Jul 18, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)650.30 | Open (Rs) 665.20 | High (Rs) 665.35 | Low (Rs) 642.05 |
| % Change-1.94 | Volume 7,553 | Value (Rs) 4,930,005 | 52-Week H/L 774.75 / 628.50 |
| Live NSE Quotes | Jul 18, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)649.20 | Open (Rs) 667.00 | High (Rs) 668.00 | Low (Rs) 640.00 |
| % Change-2.31 | Volume 273,188 | Value (Rs) 179,419,722 | 52-Week H/L 774.60 / 629.00 |
| BSE Sensex | CNX Nifty |
- Charts
-
Peer Group:
Quote & GraphPERIOD - Advanced Charts new
- Charts by TradingView
SBI LIFE INSURANCE Share Price Today:
SBI LIFE INSURANCE last traded price was down 1.9% to Rs 650.3 on the BSE. On the NSE, SBI LIFE INSURANCE last traded price was down 2.3% to Rs 649.2. The total volume of shares traded was 0.3 m.
Overall, the benchmark S&P BSE SENSEX was at 36,373.4 (down 0.4%).
Over the last 30 days, the SBI LIFE INSURANCE share price is down 3.1%. And over the last one year, SBI LIFE INSURANCE share price is up 0.0%.
|
| |
Today's Market
Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)
Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.
Related Views On News
SBI Life Insurance Company Ltd. (IPO)
Sep 19, 2017Should you subscribe to the IPO of SBI Life Insurance Company Ltd?
HDFC Standard Life Insurance Company Ltd (IPO)
Nov 6, 2017Should you subscribe to HDFC Standard Life's IPO?
New India Assurance Company Ltd. (IPO)
Oct 30, 2017Should one subscribe to the initial public offer of the market leader in the general insurance industry?
More Views on NewsMost Popular
How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)
Jul 12, 2018Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.
The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)
Jul 10, 2018If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...
The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)
Jul 11, 2018The price signals that MSP sends out, creates its own set of problems.
New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)
Jul 6, 2018ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.
When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)
Jul 6, 2018Buy Companies that can fight all kinds of Pandas and Bears in the long run.
MoreTRACK SBI LIFE INSURANCE
- Track your investment in SBI LIFE INSURANCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
OTHER USEFUL LINKS
MARKET STATS
|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.